MedTrace Logo

McGill Strengthening With and Without Integrated Neuromuscular Inhibition Technique in Piriformis Syndrome

NCT07403045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-02-11

No results posted yet for this study

Summary

The study was conducted to determine the effects of McGill strengthening exercises program with and without integrated neuromuscular inhibition technique on pain, range of motion and function in patients with piriformis syndrome.

Conditions

  • Piriformis Syndrome

Interventions

OTHER

McGill strengthening exercises program

These exercises were divided into 3 phases, each lasting 2 weeks. Patients performed 4 repetitions of each exercise during 1st and 2nd week at each hospital visit. Then, increased by 4 repetitions every 2 weeks for up to 6 weeks. These exercises were performed with a maximum of 12 repetitions with a 1-minute of rest interval between each exercise. These exercises were performed by patients at each clinical visit, 3 days per week for total of 6 weeks.

OTHER

Integrated neuromuscular inhibition technique

This technique was applied at piriformis muscle. The procedure was repeated 3 times for up to 10 minutes at each clinical visit. This intervention was performed 3 days per week for total of 6 weeks.

OTHER

Standardized physiotherapy treatment

These exercises were performed by patients at the end of each hospital visit (3 days per week for total of 6 weeks) and also at home twice a week during the 2 months follow-up period after treatment ends. 1. Continuous-mode ultrasound therapy was applied at a frequency of 1 MHz and an intensity of 1.0 W/cm² for 3 minutes to the tender or trigger points on the posterior aspect of the pelvis. 2. A hydrocollator pack (40°C) was applied for 10 minutes at lumbopelvic region. 3. Piriformis, hamstring/calf stretching was performed progressively in phases. * Phase 1 consists of weeks 1 and 2 with 1 set of 3 repetitions with 30 seconds hold per day. * Phase 2 consists of weeks 3 and 4 with 2 sets of 3 repetitions with 30 seconds hold per day. * Phase 3 consists of weeks 5 and 6 with 2 sets of 3 repetitions with 30 seconds hold twice per day. * Follow-up period consists of 2 sets of 3 repetitions with 30 seconds hold twice per day.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Syed Shakil ur Rehman, PhD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-26
Primary Completion
2025-09-05
Completion
2025-11-05

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07403045 on ClinicalTrials.gov